Replies to post #290 on Marizyme, Inc. (MRZM)

[Welcome2Pinkyland]

On September 12, 2018, we consummated an acquisition with ACB Holding AB, Reg. No. 559119-5762, a Swedish corporation, to acquire all right, title and interest in their Krillase technology in exchange for 16.98 million unregistered shares of Common Stock, shares to be issued to certain individuals and entities set forth in the asset purchase agreement. Krillase is a naturally occurring enzyme that acts to break protein bonds and has applications in dental care, wound healing and thrombosis.